Industry Focus
Healthcare: Are These Beaten-Down Clinical-Stage Biotechs Buys?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:31:01
- Mas informaciones
Informações:
Sinopsis
Geron shares tumbled after J&J jilted them and Omeros shares fell sharply following a clinical-trial update. Should you avoid these stocks, or are they bargain bin stocks worth buying? GERN OMER INCY
